Lupin And Mark Cuban Shake Hands On Spiriva Alliance In US
Indian Firm Recently Launched First Generic; Aiming For 40%+ Share
Self-labelled ‘disruptor’ Mark Cuban has brought on board yet another high-demand prescription drug, following a recent deal for biosimilar Humira.
